Hims & Hers Health Files 8-K on Shareholder Votes

TL;DR

HIMS filed an 8-K on shareholder votes - governance update.

AI Summary

Hims & Hers Health, Inc. filed an 8-K on June 10, 2024, reporting on matters submitted to a vote of security holders as of June 6, 2024. The filing details the company's corporate actions and governance, with its principal executive offices located in San Francisco, California.

Why It Matters

This filing provides transparency into the corporate governance and decision-making processes of Hims & Hers Health, Inc., which can impact investor confidence and company direction.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure regarding shareholder votes and does not indicate any immediate financial distress or significant operational changes.

Key Players & Entities

• Hims & Hers Health, Inc. (company) — Registrant
• Oaktree Acquisition Corp. (company) — Former Company Name
• June 6, 2024 (date) — Earliest event reported
• June 10, 2024 (date) — Date of report
• Delaware (jurisdiction) — State of Incorporation
• San Francisco, CA (location) — Business Address

FAQ

Key Financial Figures

• $0.0001 — which registered Class A Common Stock, $0.0001 par value HIMS New York Stock Exchange

Filing Documents

• hims-20240606.htm (8-K) — 39KB
• 0001773751-24-000185.txt ( ) — 160KB
• hims-20240606.xsd (EX-101.SCH) — 2KB
• hims-20240606_lab.xml (EX-101.LAB) — 21KB
• hims-20240606_pre.xml (EX-101.PRE) — 12KB
• hims-20240606_htm.xml (XML) — 3KB

07. Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders. (a)(b) On June 6, 2024, Hims & Hers Health, Inc. (the "Company") held its Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, the Company's stockholders voted on three proposals, each of which is described in more detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 26, 2024. Only stockholders of record as of the close of business on April 16, 2024, the record date for the Annual Meeting, were entitled to vote at the Annual Meeting. As of the record date, 206,271,215 shares of Company's Class A common stock ("Class A Common Stock") and 8,377,623 shares of the Company's Class V common stock ("Class V Common Stock") were outstanding and entitled to vote at the Annual Meeting. In deciding all matters at the Annual Meeting, the holders of our Class A Common Stock had the right to one vote for each share of Class A Common Stock they held as of the record date and the holders of our Class V Common Stock had the right to 175 votes for each share of Class V Common Stock they held as of the record date. The holders of our Class A Common Stock and Class V Common Stock voted as a single class on all matters presented at the Annual Meeting. The tabulation of the stockholders' votes on each proposal brought before the Annual Meeting is as follows: Proposal 1 : The election of eight directors to serve as directors until the 2025 annual meeting of stockholders and until their respective successors are duly elected and qualified: Name For Withheld Broker Non-Votes Andrew Dudum 1,535,010,629 25,325,876 39,080,043 Dr. Patrick Carroll, M.D. 1,541,869,586 18,466,919 39,080,043 Dr. Delos Cosgrove, M.D. 1,531,568,346 28,768,159 39,080,043 Anja Manuel 1,559,870,416 466,089 39,080,043 Christopher Payne 1,559,890,888 445,617 39,080,043 Christiane Pendarvis 1,542,365,099 17,971,406 39,080,043 Andrea Perez 1,54

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HIMS & HERS HEALTH, INC. Date: June 10, 2024 By: /s/ Andrew Dudum Andrew Dudum Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR